These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15923438)

  • 1. FDG-PET in the management of germ cell tumor.
    De Giorgi U; Pupi A; Fiorentini G; Rosti G; Marangolo M
    Ann Oncol; 2005 May; 16 Suppl 4():iv90-94. PubMed ID: 15923438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
    Oechsle K; Hartmann M; Brenner W; Venz S; Weissbach L; Franzius C; Kliesch S; Mueller S; Krege S; Heicappell R; Bares R; Bokemeyer C; de Wit M;
    J Clin Oncol; 2008 Dec; 26(36):5930-5. PubMed ID: 19018083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors.
    Buchler T; Dusek P; Brisuda A; Simonova K; Fencl P; Jarkovsky J; Babjuk M; Abrahamova J
    Klin Onkol; 2012; 25(3):178-83. PubMed ID: 22724566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediastinal germ cell tumor presenting with bone marrow metastases: an unusual pattern of relapse demonstrated with (18)F-FDG PET-CT.
    Sharma P; Sudhir SK; Dhull VS; Jain TK; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):187-8. PubMed ID: 24076038
    [No Abstract]   [Full Text] [Related]  

  • 5. [A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
    Hashizume A; Mizuno N; Kawai M; Kishida T
    Hinyokika Kiyo; 2016 Jul; 62(7):383-7. PubMed ID: 27569358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of
    Hung TJ; McLean L; Mitchell C; Pascoe C; Lawrentschuk N; Murphy DG; Iravani A; Singh D; Hofman MS; Zidan L; Akhurst T; Lewin J; Hicks RJ
    Cancer Imaging; 2019 May; 19(1):28. PubMed ID: 31142361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
    Lassen U; Daugaard G; Eigtved A; Højgaard L; Damgaard K; Rørth M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):396-402. PubMed ID: 12634968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of patients with nonseminomatous germ cell tumours and negative postchemotherapy positron emission tomography.
    Buchler T; Simonova K; Fencl P; Jarkovsky J; Abrahamova J
    Cancer Invest; 2012 Jul; 30(6):487-92. PubMed ID: 22506657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
    Cremerius U; Wildberger JE; Borchers H; Zimny M; Jakse G; Günther RW; Buell U
    Urology; 1999 Nov; 54(5):900-4. PubMed ID: 10565755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography in the diagnosis and monitoring of patients with nonseminomatous germ cell tumours].
    Büchler T; Simonová K; Fencl P; Abrahámová J
    Klin Onkol; 2011; 24(6):413-7. PubMed ID: 22257229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.
    de Wit M; Brenner W; Hartmann M; Kotzerke J; Hellwig D; Lehmann J; Franzius C; Kliesch S; Schlemmer M; Tatsch K; Heicappell R; Geworski L; Amthauer H; Dohmen BM; Schirrmeister H; Cremerius U; Bokemeyer C; Bares R
    Ann Oncol; 2008 Sep; 19(9):1619-23. PubMed ID: 18453520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CT scanning in the surveillance of testicular tumours.
    Nathan PD; Rustin GR
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):121-2. PubMed ID: 12801048
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
    Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
    BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
    Joice GA; Rowe SP; Gorin MA; Pierorazio PM
    Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
    Panicek DM; Toner GC; Heelan RT; Bosl GJ
    Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
    Schriefer P; Hartmann M; Oechsle K; Meyer CP; Klutmann S; Fisch M; Bokemeyer C; Oing C
    Urologe A; 2019 Apr; 58(4):418-423. PubMed ID: 30374517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET-positive foreign-body granuloma mimicking residual germinal tumor infiltration.
    Rehák Z; Szturz P; Krejčí E; Kocáková I
    Clin Nucl Med; 2012 Aug; 37(8):790-2. PubMed ID: 22785514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.